Thrombus - 2003

Extending the responsibility of the anticoagulation nurse
Bunis Packham
pp 1-4
Nurses have moved beyond their traditional boundaries to meet the ever-changing needs of the health service. The role of a nurse evolves in response to the needs of the society and an expanding body of nursing knowledge.With the publication of the White Papers, The New NHS. Modern, Dependable and A First Class Service. Quality in the New NHS, the government’s desire to support the expansion of nurses’ roles, both in acute care and in the community, and the emphasis it places on delivering the highest quality of service, is evident. The government has also issued The NHS Plan; and one of the document’s agenda focuses on making better use of nurses’ skills. Extending nurse prescribing is expected to improve patient care through giving patients quicker access to medication. In order to be able to provide patients with faster, easier access to the medicines, the government needs more nurses who can prescribe.
Comment: Thrombosis and anti-angiogenic drugs
Peter Rose
pp 2-2
Venous thromboembolism (VTE) is a well recognised complication in patients with advanced malignancy and in 12–15% of cases of VTE, malignancy is known at diagnosis.
Anticoagulant services – the foundation for clinical governance?
Trevor Baglin
pp 5-6
Clinical governance is a concept introduced by the Labour government in 1997 to give the quality of clinical care the same status as the financial wellbeing of healthcare organisations.
Herbal remedies – good or bad companions to anticoagulation therapy?
Andrew S Radley
pp 7-9
Herbal remedies are a popular way for individuals to prevent or treat minor ailments and to promote the feeling of general wellbeing or health. They are commonly used and are available from a wide range of sources, including specialist practitioners, pharmacies and healthfood stores. Herbal remedies are used by many people, including pregnant and breastfeeding women, children and older people.
Beating blood clots – ISTH conference, Birmingham 2003

pp 10-11
The July meeting of the International Society on Thrombosis and Haemostasis (ISTH), held at the International Convention Centre in Birmingham, was attended by more than 5,000 delegates from around the world. There were many ‘hot topics’ (three of which are reviewed below), and several interesting and, in some cases, interactive symposia.

Thrombus was previously supported by Bayer from 2014 to 2016, by Boehringer Ingelheim from 2009 to 2013, by sanofi-aventis from 2007 to 2008 and by Leo Pharma from 1998 to 2006.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Thrombus is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2019 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 1369-8117 (Print)  ISSN 2045-7855 (Online)